Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Astrid S. Ammendola"'
Autor:
Andrea Janíková, Jan Walewski, Thomas Herz, Babett Krauss, Ewa Paszkiewicz-Kozik, Gabriela Borsaru, Andrzej Hellmann, Stefan W. Henning, Agnieszka Warszewska, A. Mais, Astrid S. Ammendola
Publikováno v:
Leukemialymphoma. 60(3)
This open-label, single-arm phase II study examined efficacy, safety, pharmacokinetics, and biomarkers of histone deacetylase (HDAC) inhibitor resminostat in patients with relapsed or refractory Hodgkin lymphoma. Thirty-seven heavily pretreated patie
Autor:
Marius Horger, Tom M. Ganten, Edoardo G. Giannini, Guido Gerken, Henning Wege, Thomas Herz, B. Hauns, Marcus A. Wörns, Bernd Hentsch, Stefan W. Henning, Michael Bitzer, Armando Santoro, Astrid S. Ammendola, Stefano Pegoraro, Matthias M. Dollinger, Vincenzo Montesarchio, A. Mais, Ulrich M. Lauer, Julia Holzapfel, Franco Trevisani, Nisar P. Malek, Max E. Scheulen, Vittorina Zagonel, Jens T. Siveke, Umberto Cillo
Background & Aims No established therapies for patients with hepatocellular carcinoma (HCC) and progression on first-line sorafenib treatment currently exist. This phase I/II trial investigated safety, pharmacokinetics and potential biomarkers of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd93c56e806395c9c8a62638f98d503
https://www.ncbi.nlm.nih.gov/pubmed/26952006
https://www.ncbi.nlm.nih.gov/pubmed/26952006